medicine-news-1/amgen-named-presenting-sponsor-of-the-dempsey-challenge-3a-a-journey-for-hope-56650-3/;msg18067;topicseen

Breaking Biology Technology:BlueFire Named One of Top 20 Bioenergy Companies for Second Consecutive Year 2 BlueFire Named One of Top 20 Bioenergy Companies for Second Consecutive Year 3 BlueFire Named One of Top 20 Bioenergy Companies for Second Consecutive Year 4 VIA Pharmaceuticals Completes Patient Visits in Phase 2 Trial of VIA-2291 2 VIA Pharmaceuticals Completes Patient Visits in Phase 2 Trial of VIA-2291 3 VIA Pharmaceuticals Completes Patient Visits in Phase 2 Trial of VIA-2291 4 Caliper Life Sciences Launches Living Image(R) 4.0 Software 2 Reportlinker Adds Neurostimulation - A Global Market Perspective 2 Reportlinker Adds Neurostimulation - A Global Market Perspective 3 Reportlinker Adds Neurostimulation - A Global Market Perspective 4 Reportlinker Adds Neurostimulation - A Global Market Perspective 5 Reportlinker Adds Neurostimulation - A Global Market Perspective 6

[0] BlueFire Named One of Top 20 Bioenergy Companies for Second Consecutive Year [0] VIA Pharmaceuticals Completes Patient Visits in Phase 2 Trial of VIA-2291 [0] Caliper Life Sciences Launches Living Image(R) 4.0 Software [0] Reportlinker Adds Neurostimulation - A Global Market Perspective

Breaking Medicine Technology:Octapharma USA Announces FDA Approval of wilate(R) - the First Replacement Therapy Developed Specifically for von Willebrand Disease 2 Octapharma USA Announces FDA Approval of wilate(R) - the First Replacement Therapy Developed Specifically for von Willebrand Disease 3 Octapharma USA Announces FDA Approval of wilate(R) - the First Replacement Therapy Developed Specifically for von Willebrand Disease 4 Octapharma USA Announces FDA Approval of wilate(R) - the First Replacement Therapy Developed Specifically for von Willebrand Disease 5 ThermoGenesis Announces Agreement for Adipose Tissue Clinical Program 2 ThermoGenesis Announces Agreement for Adipose Tissue Clinical Program 3 ThermoGenesis Announces Agreement for Adipose Tissue Clinical Program 4 The Epilepsy Research Foundation and Milken Family Foundation Announce Prestigious Translational Research Grants for Two Pioneering Epilepsy Therapies 2 The Epilepsy Research Foundation and Milken Family Foundation Announce Prestigious Translational Research Grants for Two Pioneering Epilepsy Therapies 3 The Epilepsy Research Foundation and Milken Family Foundation Announce Prestigious Translational Research Grants for Two Pioneering Epilepsy Therapies 4 The Epilepsy Research Foundation and Milken Family Foundation Announce Prestigious Translational Research Grants for Two Pioneering Epilepsy Therapies 5 Plastic Surgery 2009 News Briefs Research To Be Presented on Saturday October 24 58969 1 Plastic Surgery 2009 News Briefs Research To Be Presented on Saturday October 24 58969 2 Plastic Surgery 2009 News Briefs Research To Be Presented on Saturday October 24 58969 3 Plastic Surgery 2009 News Briefs Research To Be Presented on Saturday October 24 58969 4 Plastic Surgery 2009 News Briefs Research To Be Presented on Saturday October 24 58969 5 Social Support 3A Impact on Health and the Bottom Line 58966 1 Social Support 3A Impact on Health and the Bottom Line 58966 2 Blue Cross and Blue Shield Companies Honored for Innovative Programs That Help Consumers Live Healthier Lives 58963 1 Blue Cross and Blue Shield Companies Honored for Innovative Programs That Help Consumers Live Healthier Lives 58963 2

[0] Octapharma USA Announces FDA Approval of wilate(R) - the First Replacement Therapy Developed Specifically for von Willebrand Disease [0] ThermoGenesis Announces Agreement for Adipose Tissue Clinical Program [0] The Epilepsy Research Foundation and Milken Family Foundation Announce Prestigious Translational Research Grants for Two Pioneering Epilepsy Therapies